慢性疼痛与超敏C反应蛋白对心血管风险的联合预测价值
CSTR:
作者:
作者单位:

(1.华南理工大学医学院临床医学系,广州510006;2.中国人民解放军总医院第六医学中心心血管内科,北京100037;3.解放军医学院,北京100853;4.徐州医科大学附属医院心血管病内科,江苏 徐州221300;5.南开大学医学院临床医学系,天津300071)

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(82070434/H0214)


Combined predictive value of chronic pain and high-sensitivity C-reactive protein for cardiovascular risk
Author:
Affiliation:

(1.Clinical Medicine Department, School of Medicine, South China University of Technology, Guangzhou 510006, China;2.Department of Cardiology, Sixth Medical Centre of Chinese PLA General Hospital, Beijing 100037, China;3.Chinese PLA Medical School, Beijing 100853, China;4.Department of Cardiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221200, Jiangsu Province, China;5.Clinical Medicine Department, School of Medicine, Nankai University, Tianjin 300071, China)

Fund Project:

This work was supported by National Natural Science Foundation of China(82070434/H0214).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨慢性疼痛与超敏C反应蛋白(hsCRP)对心血管疾病的联合预测价值,并开发新的心血管疾病预测模型。方法 选取2011年至2020年中国健康与老年追踪数据库中的3 041例年龄≥45岁的参与者作为样本。慢性疼痛被定义为反复出现或持续存在的身体疼痛。参与者根据慢性疼痛特征和hsCRP水平被分成4组(无痛且hsCRP<2 mg/L、无痛且hsCRP≥2 mg/L、疼痛且hsCRP<2 mg/L、疼痛且hsCRP≥2 mg/L)。心血管疾病是指由医师确诊的心脏病和(或)中风。采用R4.3.0软件进行数据分析。根据数据类型,组间比较分别采用ANOVA检验、Kruskal-Wallis检验及χ2检验。采用逻辑回归分析,探究慢性疼痛、hsCRP与新发心血管疾病风险关系;采用Lasso回归方法进行变量筛选,并将筛选的特征变量用于逻辑回归和机器学习建模;采用似然比检验评估慢性疼痛、hsCRP间的交互作用。结果 与无痛且“hsCRP<2 mg/L”的个体相比,疼痛且“hsCRP<2 mg/L”具有较高心血管疾病风险(OR=2.22; 95% CI 1.59~3.10),疼痛且“hsCRP≥2 mg/L”(OR=3.21;95%CI 2.12~4.85)的个体发生心血管疾病的风险最高(P<0.001);然而,无痛且“hsCRP≥2 mg/L”的个体差异无统计学意义(P=0.091)。慢性疼痛与hsCRP在增加心血管风险方面不存在交互作用(似然比检验:P=0.688)。利用随机森林的机器学习方法,将慢性疼痛与hsCRP联合,并加入传统心血管疾病风险因子,开发的心血管疾病预测模型具有较好的表现,受试者工作特征曲线下面积为0.944,精确率-召回率曲线下面积为0.865。结论 在中老年人群中,慢性疼痛与高hsCRP水平的联合,被视为心血管疾病的一个强有力的预测指标。我们应当加强对慢性疼痛与hsCRP在心血管疾病中的综合评估,以更全面地了解患者的健康状况,从而制定更有效的预防和治疗策略。

    Abstract:

    Objective To explore the combined predictive value of chronic pain and high-sensitivity C-reactive protein (hsCRP) for cardiovascular disease (CVD) and develop a novel prediction model for CVD. Methods The study enrolled 3 041 participants aged 45 years or older from China Health and Retirement Longitudinal Study (CHARLS) 2015-2020 database. Chronic pain was defined as recurrent or persistent body pain. Participants were divided into four groups based on chronic pain status and hsCRP levels:no pain and hsCRP <2 mg/L, no pain and hsCRP ≥2 mg/L, pain and hsCRP <2 mg/L, pain and hsCRP ≥2 mg/L. CVD was defined as heart disease and/or stroke diagnosed by the physicians. R 4.3.0 was used for data analysis. Intergroup comparison was performed using ANOVA test, Kruskal-Wallis test, orχ2 test depending on data type. Logistic regression analysis was used to investigate the relationship between chronic pain and hsCRP and CVD risk. Lasso regression method was employed for variable screening. Selected features was used in logistic regression and machine learning modeling. Likelihood ratio test evaluated the interaction between chronic pain and hsCRP. Results Individuals with chronic pain and hsCRP < 2 mg/L had a higher CVD risk than those with no pain and hsCRP < 2 mg/L (OR=2.22,95%CI 1.59-3.10; P<0.001). The CVD risk was highest in individuals with chronic pain and hsCRP≥ 2 mg/L (OR=3.21,95%CI 2.12-4.85; P<0.001). However, there was no statistically significant difference in individuals with no pain and hsCRP≥ 2 mg/L (P=0.091). There was no interaction between chronic pain and hsCRP in increasing CVD risk (likelihood ratio test:P=0.688). Using machine learning with Random Forests, a prediction model combining chronic pain, hsCRP, and traditional CVD risk factors performed well, with an area under the receiver operating characteristic curve of 0.944 and an area under the precision-recall curve of 0.865. Conclusion The combination of chronic pain and high hsCRP level is a strong CVD predictor in the middle-aged and elderly population. Comprehensive assessment of chronic pain and hsCRP in CVD should strengthened to better understand patients′ health status and develop more effective prevention and treatment strategies.

    参考文献
    相似文献
    引证文献
引用本文

杨增奥,吴正峰,蔡苏云,张鸿鸿,赵海静,朱悦,马玉涵,刘昱圻.慢性疼痛与超敏C反应蛋白对心血管风险的联合预测价值[J].中华老年多器官疾病杂志,2025,24(9):651-656
DOI:10.11915/j. issn.1671-5403.2025.09.140

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-09-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-09-22
  • 出版日期:
文章二维码